CD70 and hyperinsulinemic hypoglycemia, familial, 4: International collaboration, resulting in growing cohorts of patients with more recently described combined immunodeficiency disorders (14) including CD27 deficiency (15), CD70 deficiency (16), activated PI3Kδ and activated PI3Kδ2 syndromes (17, 18) has demonstrated comparable rates of malignancy, although the risk of case ascertainment bias must be considered in these very rare patient groups.